Silicate bioceramics for bone tissue regeneration

Wuji Cailiao Xuebao/Journal of Inorganic Materials

Volumn 28, Issue 1, 2013, Pages 29-39

  Wu, Cheng Tie ^a   Chang, Jiang ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Bone repair; Calcium phosphate bioceramics; Review; Silicate bioceramics

Indexed keywords

BONE REGENERATION; BONE REPAIR; BONE TISSUE; BONE TISSUE REGENERATION; IONIC PRODUCTS; TISSUE CELLS;

BONE; CALCIUM PHOSPHATE; GENE EXPRESSION; REVIEWS; SILICATES; TISSUE; TISSUE REGENERATION;

BIOCERAMICS;

EID: 84874476099     PISSN: 1000324X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1077.2013.12241     Document Type: Article

References (105)

1. Hench L L, Polak J M. Third-generation biomedical materials. Science, 2002, 295(5557): 1014-1017.
2. Hench L L. Bioceramics: from concept to clinic. J. Am. Ceram. Soc., 1991, 74(7): 1487-1510.
3. Hench L L. Biomaterials: a forecast for the future. Biomaterials, 1998, 19(16): 1419-1423.
4. Hench L L, Splinter R J, Greenlee T K. Bonding mechanisms at the interface of ceramic prosthetic materials. J. Biomed. Mater. Res., 1971, 5(6): 117-141.
5. Hench L L, Wilson J. An Introduction to Bioceramics. Singapore: World Scientific, 1993.
6. 2 composite materials for hard tissue repair: in vitro studies. J. Biomed. Mater. Res. A, 2008, 85(1): 72-82.
7. Lu J X, Descamps M, Dejou J, et al. The biodegradation mechanism of calcium phosphate biomaterials in bone. J. Biomed. Mater. Res., 2002, 63(4): 408-412.
8. Xu S, Lin K, Wang Z, et al. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics. Biomaterials, 2008, 29(17): 2588-2596.
9. Hench L L, Greenlee T K. 1970: Us Army Research and Development Command. Contract NO Data, 17-70-C-0001.
10. Hench L L, Thompson I. Twenty-first century challenges for biomaterials. J. R. Soc. Interface, 2010, 7(Suppl 4): S379-S391.
11. Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J. Control. Release, 2006, 110(3): 522-530.
12. Xia W, Chang J. Preparation and the phase transformation behavior of amorphous mesoporous calcium silicate. Micropor. Mesopor. Mater., 2008, 108(1/3): 345-351.
13. 2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties. Acta Biomater., 2011, 7(4): 1797-1806.
14. De Aza P N, Guitian F, Deaza S. Bioactivity of wollastonite ceramics: in vitro evaluation. Scrip. Metal. Et. Mater., 1994, 31(8): 1001-1005.
15. Mertz W. The essential trace elements. Science, 1981, 213(4514): 1332-1338.
16. Carlisle E M. Silicon: a possible factor in bone calcification. Science, 1970, 167(3916): 279-280.
17. Schwarz K, Milne D B. Growth-promoting effects of silicon in rats. Nature, 1972, 239(5371): 333-334.
18. De Aza P N, Luklinska Z B, Martinez A, et al. Morphological and structural study of pseudowollastonite implants in bone. J. Microsc., 2000, 197(1): 60-67.
19. De Aza P N, Guitian F, De Aza S. Bioeutectic: a new ceramic material for human bone replacement. Biomaterials, 1997, 18(19): 1285-1291.
20. De Aza P N, Guitian F, De Aza S, et al. Analytical control of wollastonite for biomedical applications by use of atomic absorption spectrometry and inductively coupled plasma atomic emission spectrometry. Analyst, 1998, 123(4): 681-685.
21. De Aza P N, Luklinska Z B, Anseau M R, et al. Bioactivity of pseudowollastonite in human saliva. J. Dent., 1999, 27(2): 107-113.
22. De Aza P N, Luklinska Z B, Anseau M R, et al. Reactivity of a wollastonite-tricalcium phosphate Bioeutectic ceramic in human parotid saliva. Biomaterials, 2000, 21(17): 1735-1741.
23. De Aza P N, Luklinska Z B, Anseau M R, et al. Transmission electron microscopy of the interface between bone and pseudowollastonite implant. J. Microsc., 2001, 201(Pt1): 33-43.
24. 3 scaffold for bone tissue engineering. J. Biomed. Mater. Res. A, 2006, 76(1): 196-205.
25. 4 fibers. J. Euro. Ceram. Soc., 2004, 24(13): 3491-3497.
26. Gou Z G, Chang J. Synthesis and in vitro bioactivity of dicalcium silicate powders. J. Euro. Ceram. Soc., 2004, 24(1): 93-99.
27. Gou Z R, Chang J, Zhai W Y. Preparation and characterization of novel bioactive dicalcium silicate ceramics. J. Euro. Ceram. Soc., 2005, 25(9): 1507-1514.
28. 4. J. Biomed. Mater. Res. B-App. Biomater., 2005, 73B(2): 244-251.
29. Huang X H, Chang J. Low-temperature synthesis of nanocrystalline beta-dicalcium silicate with high specific surface area. J. Nanoparticle Res., 2007, 9(6): 1195-1200.
30. 4 ceramics synthesized by spark plasma sintering. Ceram. Int., 2011, 37(7): 2459-2465.
31. Zhao W, Wang J, Zhai W, et al. The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials, 2005, 26(31): 6113-6121.
32. Zhao W, Chang J. Preparation and characterization of novel tricalcium silicate bioceramics. J. Biomed. Mater. Res. A, 2005, 73(1): 86-89.
33. Zhao W, Chang J, Wang J, et al. In vitro bioactivity of novel tricalcium silicate ceramics. J. Mater. Sci. Mater. Med., 2007, 18(5): 917-923.
34. 2O composite cement. J. Biomed. Mater. Res. A, 2008, 85(2): 336-344.
35. Peng W, Liu W, Zhai W, et al. Effect of tricalcium silicate on the proliferation and odontogenic differentiation of human dental pulp cells. J. Endod., 2011, 37(9): 1240-1246.
36. 4) bioceramics. Ceram. Int., 2007, 33(1): 83-88.
37. Ni S, Chang J. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics. J. Biomater. Appl., 2009, 24(2): 139-158.
38. 2-MgO system composite bioceramics. J. Mater. Sci. Mater. Med., 2008, 19(1): 359-367.
39. Kharaziha M, Fathi M H. Improvement of mechanical properties and biocompatibility of forsterite bioceramic addressed to bone tissue engineering materials. J. Mech. Behav. Biomed. Mater., 2010, 3(7): 530-537.
40. Tavangarian F, Emadi R. Nanostructure effects on the bioactivity of forsterite bioceramic. Mater. Lett., 2011, 65(4): 740-743.
41. Tavangarian F, Emadi R. Improving degradation rate and apatite formation ability of nanostructure forsterite. Ceram. Int., 2011, 37(7): 2275-2280.
42. Tavangarian F, Emadi R. Synthesis and characterization of spinel forsterite nanocomposites. Ceram. Int., 2011, 37(7): 2543-2548.
43. Tavangarian F, Emadi R. Effects of mechanical activation and chlorine ion on nanoparticle forsterite formation. Mater. Lett., 2011, 65(1): 126-129.
44. Jin X G, Chang J A, Zhai W Y, et al. Preparation and characterization of clinoenstatite bioceramics. J. Am. Ceram. Soc., 2011, 94(1): 173-177.
45. Zhang M, Zhai W, Chang J. Preparation and characterization of a novel willemite bioceramic. J. Mater. Sci. Mater. Med., 2010, 21(4): 1169-1173.
46. Zhang M, Zhai W, Lin K, et al. Synthesis, in vitro hydroxyapatite forming ability, and cytocompatibility of strontium silicate powders. J. Biomed. Mater. Res. B Appl. Biomater., 2010, 93(1): 252-257.
47. Wu C T, Chang J. Synthesis and apatite-formation ability of akermanite. Mater. Lett., 2004, 58(19): 2415-2417.
48. Wu C, Chang J. A novel akermanite bioceramic: preparation and characteristics. J. Biomater. Appl., 2006, 21(2): 119-129.
49. Wu C, Chang J, Ni S, et al. In vitro bioactivity of akermanite ceramics. J. Biomed. Mater. Res. A, 2006, 76(1): 73-80.
50. Wu C, Chang J, Zhai W, et al. Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies. J. Biomed. Mater. Res. B Appl. Biomater., 2006, 78(1): 47-55.
51. Wu C, Chang J. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. J. Biomed. Mater. Res. B Appl. Biomater., 2007, 83(1): 153-160.
52. Sun H, Wu C, Dai K, et al. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite- bioactive ceramics. Biomaterials, 2006, 27(33): 5651-5657.
53. Huang Y, Jin X, Zhang X, et al. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials, 2009, 30(28): 5041-5048.
54. Liu Q, Cen L, Yin S, et al. A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics. Biomaterials, 2008, 29(36): 4792-4799.
55. Gu H, Guo F, Zhou X, et al. The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway. Biomaterials, 2011, 32(29): 7023-7033.
56. Xia L, Zhang Z, Chen L, et al. Proliferation and osteogenic differentiation of human periodontal ligament cells on akermanite and beta-TCP bioceramics. Eur. Cell Mater., 2011, 22: 68-82.
57. Zhai W, Lu H, Chen L, et al. Silicate bioceramics induce angiogenesis during bone regeneration. Acta Biomater., 2012, 8(1): 341-349.
58. Wu C, Chang J, Wang J, et al. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic. Biomaterials, 2005, 26(16): 2925-2931.
59. Wu C, Chang J. Synthesis and in vitro bioactivity of bredigite powders. J. Biomater. Appl., 2007, 21(3): 251-263.
60. 16) scaffold with biomimetic apatite layer for bone tissue engineering. J. Mater. Sci. Mater. Med., 2007, 18(5): 857-864.
61. Huang X H, Chang J. Preparation of nanocrystalline bredigite powders with apatite-forming ability by a simple combustion method. Mater. Res. Bull., 2008, 43(6): 1615-1620.
62. Miake Y, Yanagisawa T, Yajima Y, et al. High-resolution and analytical electron microscopic studies of new crystals induced by a bioactive ceramic (diopside). J. Dent. Res., 1995, 74(11): 1756-1763.
63. Nonami T, Tsutsumi S. Study of diopside ceramics for biomaterials. J. Mater. Sci. Mater. Med., 1999, 10(8): 475-479.
64. 6) scaffold: a promising bioactive material for bone tissue engineering. Acta Biomater., 2010, 6(6): 2237-2245.
65. 6) ceramic microspheres for drug delivery. Acta Biomater., 2010, 6(3): 820-829.
66. Ou J, Kang Y, Huang Z, et al. Preparation and in vitro bioactivity of novel merwinite ceramic. Biomed. Mater., 2008, 3(1): 015015.
67. 2) via Sol-Gel method. Ceram. Int., 2011, 37(1): 175-180.
68. Chen X, Ou J, Kang Y, et al. Synthesis and characteristics of monticellite bioactive ceramic. J. Mater. Sci. Mater. Med., 2008, 19(3): 1257-1263.
69. Wu C, Chang J, Zhai W. A novel hardystonite bioceramic: preparation and characteristics. Ceram. Int., 2005, 31(1): 27-31.
70. Ramaswamy Y, Wu C, Zhou H, et al. Biological response of human bone cells to zinc-modified Ca-Si-based ceramics. Acta Biomater., 2008, 4(5): 1487-1497.
71. 7) and β-TCP ceramics. J. Biomater. Appl., 2010, 25(1): 39-56.
72. Wu C, Ramaswamy Y, Chang J, et al. The effect of Zn contents on phase composition, chemical stability and cellular bioactivity in Zn-Ca-Si system ceramics. J. Biomed. Mater. Res. B: Appl. Biomater., 2008, 87(2): 346-353.
73. 3 ceramics on their physical and biological properties. Biomaterials, 2007, 28(21): 3171-3181.
74. Zhang W, Shen Y, Pan H, et al. Effects of strontium in modified biomaterials. Acta Biomater., 2011, 7(2): 800-808.
75. Wu C, Ramaswamy Y, Soeparto A, et al. Incorporation of titanium into calcium silicate improved their chemical stability and biological properties. J. Biomed. Mater. Res. A, 2008, 86(2): 402-410.
76. 5 ceramic coating on Ti-6Al-4V with excellent bonding strength, stability and cellular bioactivity. J. R. Soc. Interface, 2009, 6(31): 159-168.
77. Wu C, Ramaswamy Y, Gale D, et al. Novel sphene coatings on Ti-6Al-4V for orthopedic implants using Sol-Gel method. Acta Biomater., 2008, 4(3): 569-576.
78. Ramaswamy Y, Wu C, Dunstan C R, et al. Sphene ceramics for orthopedic coating applications: an in vitro and in vivo study. Acta Biomater., 2009, 5(8): 3192-3204.
79. Ramaswamy Y, Wu C, Van Hummel A, et al. The responses of osteoblasts, osteoclasts and endothelial cells to zirconium modified calcium-silicate-based ceramic. Biomaterials, 2008, 29(33): 4392-4402.
80. 4 bioceramic. J. Biomater. Appl., 2010, 26(6): 637-650.
81. 4 and its in vitro biological behaviors. J. Sol-Gel Sci. Tech., 2009, 52(1): 69-74.
82. 9. J. Mater. Sci. Mater. Med., 2004, 15(12): 1285-1289.
83. Zreiqat H, Ramaswamy Y, Wu C, et al. The incorporation of strontium and zinc into a calcium-silicon ceramic for bone tissue engineering. Biomaterials, 2010, 31(12): 3175-3184.
84. 2006.
85. 3 ceramics. Ceram. Int., 2005, 31(2): 323-326.
86. 3 ceramic with high mechanical strength and HAp formation ability in simulated body fluid. J. Euro. Ceram. Soc., 2006, 26(9): 1701-1706.
87. Gou Z R, Chang J, Zhai W Y. Preparation and characterization of novel bioactive dicalcium silicate ceramics. J. Europ. Ceram. Soc., 2005, 25(9): 1507-1514.
88. 2 (3Y) nanocomposites. J. Eur.o Ceram. Soc., 2008, 28(15): 2883-2887.
89. Hodgskinson R, Currey J D. Effects of structural variation on Young's modulus of non-human cancellous bone. Proc. Inst. Mech. Eng. H., 1990, 204(1): 43-52.
90. Hodgskinson R, Currey J D. The effect of variation in structure on the Young's modulus of cancellous bone: a comparison of human and non-human material. Proc. Inst. Mech. Eng. H., 1990, 204(1): 115-121.
91. Morgan E F, Yetkinler D N, Constantz B R, et al. Mechanical properties of carbonated apatite bone mineral substitute: strength, fracture and fatigue behaviour. J. Mater. Sci. Mater. Med., 1997, 8(9): 559-570.
92. Hull D, Clyne T W. An Introduction to Composite Materials. 2nd ed, Cambridge: Cambridge University Press, 1996: 78.
93. El-Ghannam A, Ducheyne P, Shapiro I M. Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix. Biomaterials, 1997, 18(4): 295-303.
94. Black L, Stumm A, Garbev K, et al. X-ray photoelectron spectroscopy of the cement clinker phases tricalcium silicate and beta-dicalcium silicate. Cem. Concr. Res., 2003, 33(10): 1561-1565.
95. Richardson I G. The nature of the hydration products in hardened cement pastes. Cem. Concr. Comp., 2000, 22(2): 97-113.
96. 2O Composite Bone Cement. J. Biomed. Mater. Res. B Appl. Biomater., 2008, 87B(2): 387-394.
97. Huan Z, Chang J. Self-setting properties and in vitro bioactivity of calcium sulfate hemihydrate-tricalcium silicate composite bone cements. Acta Biomater., 2007, 3(6): 952-960.
98. Huan Z, Chang J. Novel tricalcium silicate/monocalcium phosphate monohydrate composite bone cement. J. Biomed. Mater. Res. B Appl Biomater., 2007, 82(2): 352-359.
99. Huan Z, Chang J. Novel bioactive composite bone cements based on the beta-tricalcium phosphate-monocalcium phosphate monohydrate composite cement system. Acta Biomater., 2009, 5(4): 1253-1264.
100. Kobayashi M, Nakamura T, Tamura J, et al. Bioactive bone cement: comparison of AW-GC filler with hydroxyapatite and beta-TCP fillers on mechanical and biological properties. J. Biomed. Mater. Res., 1997, 37(3): 301-313.
101. Kobayashi M, Nakamura T, Okada Y, et al. Bioactive bone cement: comparison of apatite and wollastonite containing glass-ceramic, hydroxyapatite, and beta-tricalcium phosphate fillers on bone-bonding strength. J. Biomed. Mater. Res., 1998, 42(2): 223-237.
102. Lin K L, Chang J, Zeng Y, et al. Preparation of macroporous calcium silicate ceramics. Mater. Lett., 2004, 58(15): 2109-2113.
103. Lin K L, Chang J, Liu Z W, et al. Fabrication and characterization of 45S5 bioglass reinforced macroporous calcium silicate bioceramics. J. Euro. Ceram. Soc., 2009, 29(14): 2937-2943.
104. 3 scaffolds by poly (D, L-lactic acid) modification. Acta Biomater., 2008, 4(2): 343-353.
105. Bohner M. Silicon-substituted calcium phosphates: a critical view. Biomaterials, 2009, 30(32): 6403-6406.